
Join to View Full Profile
1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Dr. Kadakia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Texas M D Anderson Cancer CenterFellowship, Hospice and Palliative Medicine, 2012 - 2013
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
Northeast Ohio Medical UniversityClass of 2009
Certifications & Licensure
NC State Medical License 2016 - 2026
MI State Medical License 2013 - 2017
OH State Medical License 2014 - 2016
TX State Medical License 2012 - 2014
MN State Medical License 2010 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Next Gen Innovator HemOnc Today, 2018
- Honorary Co-Chair Pancreatic Cancer Action Network, PurpleStride Charlotte, NC, 2018
- Fellow of the American College of Physicians American College of Physicians, 2016
- Join now to see all
Clinical Trials
- Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma Start of enrollment: 2022 Jun 17
Publications & Presentations
PubMed
- 1 citationsNutrition assessment defects in cancer clinical trials.Ye Myint Aung, Aynur Aktas, Vishal Shroff, Kunal Kadakia, Jake Waldman
BMJ Supportive & Palliative Care. 2025-10-27 - Study design and methods for the physical activity index (PAI) feasibility pilot trial for breast and colon cancer survivors in North Carolina.Shirley M Bluethmann, Janet Tooze, Joni K Evans, Jeffrey Katula, Kristy Wood
Contemporary Clinical Trials Communications. 2025-10-01 - Neoadjuvant treatment in resectable pancreatic cancer: Why is upfront surgery so hard to be beaten?Pedro Luiz Serrano Uson Junior, Kunal C Kadakia, Raphael L C Araujo
World Journal of Clinical Oncology. 2025-09-24
Journal Articles
- Commentary on A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast ...Kadakia K.C., Henry, N.L., . Breast Diseases: A Year Book Quarterly., 11/2014
Books/Book Chapters
Abstracts/Posters
- Nintedanib in metastatic appendiceal carcinoma1. Birendra KC, Ahmad MN, Kadakia KC, Nazemzadeh R, Salem ME, Chai S, Salmon JS, Symanowski JT, Boselli D, Hwang JJ, 2019 Gastrointestinal Cancers Symposium, San Francisco, CA, 1/19/2019
- Examination of factors that influence use of extended adjuvant endocrine therapy (ET).Kadakia KC, Kidwell KM, Barton DL, Griggs J, Henry NL, 2017 ASCO Annual Meeting; (suppl; abstr e21618), Chicago, IL, 4/3/2017
- Crossover from one aromatase inhibitor (AI) to another in the Exemestane (E) and Letrozole (L) Pharmacogenetics (ELPh) trial.Kadakia KC, Kidwell KM, Stearns V, Hayes DF, Henry NL, et. al., ASCO Cancer Survivorship Symposium: Advancing Care and Research – A Primary Care and Oncology Symposium, San Francisco, CA, 1/16/2016
- Join now to see all
Committees
- Levine Cancer Institute, Hematology and Oncology Fellowship Program, Fellowship Program Evaluation Committee Member 2018 - Present
- Levine Cancer Institute, Charlotte, NC, Data Safety Monitoring Board (DSMB), Member 2017 - Present
- Member, House Officer Quality & Safety Council 2015 - 2016
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









